Skip to content

Operating margin at other companies

HRO
HarrowHROW
7.3%+5.2pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-103.9%-43.0pp
XER
Xeris Biopharma Holdings, Inc.XERS
11.4%+7.7pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-83.8%-3.0pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
13.4%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-3,020.3%-1,463pp

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed November 12, 2024, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s operating margin?
Eton Pharmaceuticals, Inc. (ETON) reported operating margin of -15.1% in Q3 2024.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.